Stronger Cautions Backed on Bone Drugs for Women

http://www.nytimes.com/2011/09/10/business/fda-panels-back-sterner-language-on-bone-drugs.html?_r=1&hpw

Two advisory panels to the Food and Drug Administration on Friday recommended increasing the cautionary language on the product labels of bone-building drugs taken by more than five million women in the United States.

But they stopped short of specifying what the safety warnings should say and did not recommend limiting use of the drugs to a proposed five years. About 11 percent of women 55 and older take the drugs to prevent bone fractures.